Micaela Trexler Joins Seraph Biosciences
This past week Micaela Trexler, a doctoral candidate of Biomedical Engineering at Wayne State University, joined Seraph’s product development team as a Senior Scientist. Micaela began her biomedical research experience studying applications of Raman Spectroscopy in cancer diagnostics with Seraph’s Chief Science Officer, Dr. Gregory Auner.
She leveraged this experience as a graduate student at Boston University’s Biomedical Engineering M.Eng program, where she had the opportunity to assist a cardiac surgery team with the research and development of advanced surgical tools to prepare for the FDA process. Reflecting on her early-stage research experiences and passion for product development, Micaela understood the imminence of public health crises involving infectious diseases and chose to focus her doctoral research on novel Raman-spectroscopy based diagnostic and identification techniques for Influenza virus.
Micaela’s research interests have never been more relevant as the scientific world scrambles to develop novel diagnostic solutions for the COVID-19 pandemic. “The alarming emphasis on the importance of early detection and diagnosis has stuck with me since I started my doctoral research”, said Micaela, “This pandemic has come at a terrible human cost and we need technologies like Seraspec® that are agile and quickly adaptable to infectious pathogens that are here, now. Whether that is SARS-CoV-2 or antibiotic resistant “super bug bacteria”.
It is this reality that motivated Micaela to apply her unique experience and understanding of Raman spectroscopy as a team member at Seraph. “I am thrilled to join a team of individuals with proven track records to do great things in the diagnostic space”, said Micaela, “As I near the finish line of my doctoral research I am excited to see where this ride goes”. Welcome, Micaela!